A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

NCT03351738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Coronary Heart Disease

Interventions

DRUG: MEDI5884
DRUG: Placebo

Sponsor

MedImmune LLC